Renal cell carcinoma (RCC) refers to a heterogenous group of cancers that originate in the proximal convoluted tubule of the kidney. The three most common forms of RCC are clear cell RCC ...

The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC ... and an increasing number of risk factors were associated with a higher risk of death. 4 While randomized controlled ...

Cadonilimab is under clinical development by Akeso and currently in Phase II for Metastatic Renal Cell Carcinoma.

Considering taking supplements to treat renal cell carcinoma? Below is a list of common natural remedies used to treat or reduce the symptoms of renal cell carcinoma. Follow the links to read ...

Real-world data supports Opdivo plus Yervoy efficacy for advanced renal cell carcinoma, mirroring clinical trial results.

The discovery could help explain why some cancer patients respond well to certain treatments, while others are not so lucky.

Updated overall survival data from KEYNOTE-564 showed adjuvant pembrolizumab benefits in clear cell renal cell carcinoma, but some patients remain unresponsive.

Durvalumab is under clinical development by AstraZeneca and currently in Phase II for Neuroendocrine Carcinoma.

Nivolumab is a programmed death-1 (PD-1) immune checkpoint inhibitor that is designed to uniquely ... esophageal squamous cell carcinoma or adenocarcinoma, mesothelioma, renal cell carcinoma. About ...